Skip to main content
Signal8
Tong Victor Edward Jr profile photo

Victor Edward Tong Jr.

CIK: 0002007923

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Aardvark Therapeutics, Inc. logo
AARD

Aardvark Therapeutics, Inc.

Director
CG Oncology, Inc. logo
CGON

CG Oncology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Aug 14, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    45K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Jun 4, 2026
    Award(A)

    Director Stock Option (right to buy)

    Direct
    9.4K shares-
  • Aardvark Therapeutics, Inc. logo
    AARD

    Aardvark Therapeutics, Inc.

    Jun 11, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    61K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Jun 5, 2025
    Award(A)

    Director Stock Option (right to buy)

    Direct
    24.2K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Oct 4, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    15.6K shares-

1-5 of 5

About Tong Victor Edward Jr

Tong Victor Edward Jr (SEC CIK 0002007923) files insider reports with the SEC as Director of Aardvark Therapeutics, Inc. (AARD) and Director of CG Oncology, Inc. (CGON).

Signal8 holds 6 ownership filings by Tong Victor Edward Jr (1 Form 3, 5 Form 4), filed between Oct 7, 2024 and Aug 21, 2026. Those filings report 5 transactions, from Oct 4, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tong Victor Edward Jr's filings is in SAN DIEGO, CA.

Recent filings by Tong Victor Edward Jr

  • Aug 14, 2026: Grant or award of AARD derivative securities (Form 4, code A).
  • Jun 4, 2026: Grant or award of CGON derivative securities (Form 4, code A).
  • Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).
  • Jun 5, 2025: Grant or award of CGON derivative securities (Form 4, code A).
  • Oct 4, 2024: Grant or award of CGON derivative securities (Form 4, code A).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

How to read Form 4 transaction codes